SCHEMBL19683456

SCHEMBL19683456

COc1cc2c(OC)cccc2cc1-c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.55
HPGD P15428 2/20 0.55
ALDH1A1 P00352 2/20 0.55
HSD17B10 Q99714 1/20 0.55
NPC1 O15118 4/20 0.54
RAB9A P51151 4/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
MAPT P10636 2/20 0.54
PKM P14618 1/20 0.54
PGR P06401 1/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ATM Q13315 1/20 0.50
NQO1 P15559 1/20 0.48
LMNA P02545 3/20 0.45
BCHE P06276 1/20 0.45
ACHE P22303 1/20 0.45
ACACA Q13085 1/20 0.43
CYP1A1 P04798 1/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16810204 0.83 PGR (0.58) KDM4EHPGDALDH1A1HSD17B10NPC1
SCHEMBL19683672 0.81 PGR (0.60) KDM4EHPGDALDH1A1HSD17B10NPC1
SCHEMBL26259890 0.81 PGR (0.60) KDM4EHPGDALDH1A1HSD17B10NPC1
SCHEMBL24049723 0.79 PGR (0.56) KDM4EHPGDALDH1A1NPC1RAB9A
SCHEMBL29919905 0.79 NQO1 (0.67) KDM4EHPGDALDH1A1HSD17B10NPC1
SCHEMBL8393507 0.79 NQO1 (0.67) KDM4EHPGDALDH1A1HSD17B10NPC1
SCHEMBL19123522 0.79 ALDH1A1 (0.48) KDM4EHPGDALDH1A1HSD17B10RAB9A
SCHEMBL17726898 0.78 CTSL (0.50) ALDH1A1NPC1RAB9AMAPTMEN1
SCHEMBL18076337 0.78 CYP1A1 (0.61) KDM4EHPGDALDH1A1NPC1RAB9A
SCHEMBL1003225 0.77 NQO1 (0.72) KDM4EHPGDALDH1A1HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304595-A1 Electroactive Compounds LG CHEM, LTD. (KR) 2025-10-02 US disclosed
US-12384796-B2 Electroactive compounds LG CHEM, LTD. (KR) 2025-08-12 US disclosed
CN-109153684-B Electroactive compounds 株式会社LG化学 2021-12-21 CN disclosed
CN-109153684-A Electroactive compound E.I.内穆尔杜邦公司 2019-01-04 CN disclosed
WO-2017210072-A1 ELECTROACTIVE COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2017-12-07 WO disclosed
WO-2017210072-A1 ELECTROACTIVE COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2017-12-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304595-A1 Electroactive Compounds NAT1, NES, SULT1E1 KDM4E 3574/4885HPGD 1328/4885ALDH1A1 1162/4885
US-12384796-B2 Electroactive compounds NES, NAT1, SCN1B KDM4E 3755/4885HPGD 1344/4885ALDH1A1 1194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.